J
Jochen H. H. Ehrich
Researcher at Hannover Medical School
Publications - 255
Citations - 8427
Jochen H. H. Ehrich is an academic researcher from Hannover Medical School. The author has contributed to research in topics: Transplantation & Renal function. The author has an hindex of 46, co-authored 254 publications receiving 7811 citations. Previous affiliations of Jochen H. H. Ehrich include Hochschule Hannover & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good,Petra Zürbig,Àngel Argilés,Hartwig W. Bauer,Georg M. N. Behrens,Joshua J. Coon,Mohammed Dakna,Stéphane Decramer,Christian Delles,Anna F. Dominiczak,Jochen H. H. Ehrich,Frank Eitner,Danilo Fliser,Moritz Frommberger,Arnold Ganser,Mark Girolami,Igor Golovko,Wilfried Gwinner,Marion Haubitz,Stefan Herget-Rosenthal,Joachim Jankowski,Holger Jahn,George Jerums,Bruce A. Julian,Markus Kellmann,Volker Kliem,Walter Kolch,Andrzej S. Krolewski,Andrzej S. Krolewski,Mario Luppi,Ziad A. Massy,Michael Melter,Christian Neusüss,Jan Novak,Karlheinz Peter,Kasper Rossing,Harald D. Rupprecht,Joost P. Schanstra,Eric Schiffer,Jens-Uwe Stolzenburg,Lise Tarnow,Dan Theodorescu,Visith Thongboonkerd,Raymond Vanholder,Eva M. Weissinger,Harald Mischak,Philippe Schmitt-Kopplin +46 more
TL;DR: The establishment of a reproducible, high resolution method for peptidome analysis of naturally occurring human urinary peptides and proteins, ranging from 800 to 17,000 Da, using samples from 3,600 individuals analyzed by capillary electrophoresis coupled to MS is reported.
Journal ArticleDOI
Clinical proteomics: A need to define the field and to begin to set adequate standards.
Harald Mischak,Rolf Apweiler,Rosamonde E. Banks,Mark R. Conaway,Joshua J. Coon,Anna F. Dominiczak,Jochen H. H. Ehrich,Danilo Fliser,Mark Girolami,Henning Hermjakob,Denis F. Hochstrasser,Denis F. Hochstrasser,Joachim Jankowski,Bruce A. Julian,Walter Kolch,Ziad A. Massy,Christian Neusuess,Jan Novak,Karlheinz Peter,Kasper Rossing,Joost P. Schanstra,O. John Semmes,Dan Theodorescu,Visith Thongboonkerd,Eva M. Weissinger,Jennifer E. Van Eyk,Tadashi Yamamoto +26 more
TL;DR: It is argued that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples, but should be to address clinically relevant questions and to improve the state-of-the‐art, both in diagnosis and in therapy of diseases.
Journal ArticleDOI
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Harald Mischak,Guenter Allmaier,Rolf Apweiler,Teresa K. Attwood,Marc Baumann,Ariela Benigni,Samuel E. Bennett,Rainer Bischoff,Erik Bongcam-Rudloff,Giovambattista Capasso,Joshua J. Coon,Patrick C. D'Haese,Anna F. Dominiczak,Mohammed Dakna,Hassan Dihazi,Jochen H. H. Ehrich,Patricia Fernández-Llama,Danilo Fliser,Jørgen Frøkiær,Jérôme Garin,Mark Girolami,William S. Hancock,Marion Haubitz,Denis F. Hochstrasser,Rury R. Holman,John P. A. Ioannidis,Joachim Jankowski,Bruce A. Julian,Jon B. Klein,Walter Kolch,Theo M. Luider,Ziad A. Massy,William B. Mattes,Franck Molina,Bernard Monsarrat,Jan Novak,Karlheinz Peter,Peter Rossing,Marta Sanchez-Carbayo,Joost P. Schanstra,O. John Semmes,Goce Spasovski,Dan Theodorescu,Visith Thongboonkerd,Raymond Vanholder,Timothy D. Veenstra,Eva M. Weissinger,Tadashi Yamamoto,Antonia Vlahou +48 more
TL;DR: It is asserted that successful studies generally use suitable statistical approaches for biomarker definition and confirm results in independent test sets and a brief set of practical and feasible recommendations are described for investigators to properly identify and qualify proteomic biomarkers, which could also be used as reporting requirements.
Journal ArticleDOI
Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria
René Santer,Martina Kinner,C.L. Lassen,Reinhard Schneppenheim,Paul Eggert,Martin Bald,Johannes Brodehl,Markus Daschner,Jochen H. H. Ehrich,Markus J. Kemper,Salvatore Li Volti,Thomas J. Neuhaus,Flemming Skovby,Peter G.F. Swift,Jürgen Schaub,Dan Klaerke +15 more
TL;DR: It is concluded that SGLT2 plays an important role in renal tubular glucose reabsorption and Inheritance of renal glucosuria shows characteristics of a codominant trait with variable penetrance.
Journal ArticleDOI
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
Oliver Gross,Christoph Licht,Hans J. Anders,Bernd Hoppe,Bodo B. Beck,Burkhard Tönshoff,Britta Höcker,Simone Wygoda,Jochen H. H. Ehrich,Lars Pape,Martin Konrad,Wolfgang Rascher,Jörg Dötsch,Dirk E. Müller-Wiefel,Peter F. Hoyer,Bertrand Knebelmann,Yves Pirson,Jean-Pierre Grünfeld,Patrick Niaudet,Pierre Cochat,Laurence Heidet,Said Lebbah,Roser Torra,Tim Friede,Katharina Lange,Gerhard A. Müller,Manfred Weber +26 more
TL;DR: Alport syndrome is treatable with angiotensin-converting enzyme inhibition to delay renal failure and therapy improves life expectancy in a time-dependent manner and supports the need for early diagnosis and early nephroprotective therapy in oligosymptomatic patients.